Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN): Price and Financial Metrics

Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN): $38.33

0.66 (-1.69%)

POWR Rating

Component Grades








Add BHVN to Watchlist
Sign Up

Industry: Biotech




#287 of 360

in industry

BHVN Price/Volume Stats

Current price $38.33 52-week high $62.21
Prev. close $38.99 52-week low $12.35
Day low $38.19 Volume 1,132,200
Day high $39.70 Avg. volume 1,243,213
50-day MA $51.49 Dividend yield N/A
200-day MA $34.96 Market Cap 3.14B

BHVN Stock Price Chart Interactive Chart >

Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN) Company Bio

Biohaven Pharmaceutical Holding Company Ltd., a clinical-stage biopharmaceutical company, develops product candidates to treat neurological diseases, including rare disorders. The company was founded in 2013 and is based in New Haven, Connecticut.

BHVN Latest News Stream

Event/Time News Detail
Loading, please wait...

BHVN Latest Social Stream

Loading social stream, please wait...

View Full BHVN Social Stream

Latest BHVN News From Around the Web

Below are the latest news stories about BIOHAVEN LTD that investors may wish to consider to help them evaluate BHVN as an investment opportunity.

Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting

Biohaven Ltd. (NYSE: BHVN) announced today that it is presenting expanded EEG and safety data for BHV-7000 at the 2023 American Epilepsy Society (AES) Annual Meeting, taking place December 1-5, 2023, in Orlando, Florida. The presentations include results from the BHV-7000 Phase 1 EEG biomarker study and additional BHV-7000 safety and tolerability data from Phase 1 single ascending dose (SAD) / multiple ascending dose (MAD) studies. Additional posters showcase BHV-7000's preclinical data, finding

Yahoo | December 1, 2023

Will Biohaven (NYSE:BHVN) Spend Its Cash Wisely?

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Biohaven...

Yahoo | November 22, 2023

Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?

Here is how Biohaven Ltd. (BHVN) and Blueprint Medicines (BPMC) have performed compared to their sector so far this year.

Yahoo | November 16, 2023

Biohaven Ltd (BHVN) Reports Q3 2023 Financial Results: Advances in Clinical Programs and Strong ...

Key Developments Include Progress in Immunology and CNS Programs, Enhanced by Successful Public Offering

Yahoo | November 15, 2023

Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the third quarter ended September 30, 2023, and provided a review of recent accomplishments and anticipated upcoming milestones.

Yahoo | November 14, 2023

Read More 'BHVN' Stories Here

BHVN Price Returns

1-mo -31.37%
3-mo -15.94%
6-mo 36.94%
1-year 176.35%
3-year N/A
5-year N/A
YTD -10.44%
2023 208.36%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!